Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept crossover study of an investigational test compound in chronic subjective tinnitus
NL-OMON36809Phase 2Active, not recruiting
- Sponsor
- Novartis
- Start
- Jan 2011
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus (2 arms), sponsored by Novartis. Started Jan 2011; status: active, not recruiting.
02
Conditions
tinnitus
Beyond the preview
Go deeper on NL-OMON36809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36809.